JBIO Collar Strategy
JBIO (Jade Biosciences, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Jade Biosciences, Inc. is a biotechnology company focused on developing best-in-class therapies to address critical unmet needs in autoimmune diseases. Their lead asset, JADE-001, targets the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for the treatment of immunoglobulin A (IgA) nephropathy. JADE-001 is anticipated to enter clinical trials in the second half of 2025, with initial data expected in the first half of 2026. The company's pipeline also includes two preclinical antibody programs, JADE-002 and JADE-003.
JBIO (Jade Biosciences, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $817.9M, a beta of 1.52 versus the broader market, a 52-week range of 6.565-28, average daily share volume of 548K, a public-listing history dating back to 2025, approximately 50 full-time employees. These structural characteristics shape how JBIO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.52 indicates JBIO has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. JBIO pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a collar on JBIO?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current JBIO snapshot
As of May 15, 2026, spot at $23.54, ATM IV 152.80%, IV rank 24.68%, expected move 43.81%. The collar on JBIO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this collar structure on JBIO specifically: IV regime affects collar pricing on both sides; compressed JBIO IV at 152.80% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 43.81% (roughly $10.31 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated JBIO expiries trade a higher absolute premium for lower per-day decay. Position sizing on JBIO should anchor to the underlying notional of $23.54 per share and to the trader's directional view on JBIO stock.
JBIO collar setup
The JBIO collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With JBIO near $23.54, the first option leg uses a $24.72 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed JBIO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 JBIO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $23.54 | long |
| Sell 1 | Call | $24.72 | N/A |
| Buy 1 | Put | $22.36 | N/A |
JBIO collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
JBIO collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on JBIO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on JBIO
Collars on JBIO hedge an existing long JBIO stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
JBIO thesis for this collar
The market-implied 1-standard-deviation range for JBIO extends from approximately $13.23 on the downside to $33.85 on the upside. A JBIO collar hedges an existing long JBIO position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current JBIO IV rank near 24.68% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on JBIO at 152.80%. As a Healthcare name, JBIO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to JBIO-specific events.
JBIO collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. JBIO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move JBIO alongside the broader basket even when JBIO-specific fundamentals are unchanged. Always rebuild the position from current JBIO chain quotes before placing a trade.
Frequently asked questions
- What is a collar on JBIO?
- A collar on JBIO is the collar strategy applied to JBIO (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With JBIO stock trading near $23.54, the strikes shown on this page are snapped to the nearest listed JBIO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are JBIO collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the JBIO collar priced from the end-of-day chain at a 30-day expiry (ATM IV 152.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a JBIO collar?
- The breakeven for the JBIO collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current JBIO market-implied 1-standard-deviation expected move is approximately 43.81%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on JBIO?
- Collars on JBIO hedge an existing long JBIO stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current JBIO implied volatility affect this collar?
- JBIO ATM IV is at 152.80% with IV rank near 24.68%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.